Comparative study on serum levels of macro and trace elements in schizophrenia based on supervised learning methods

被引:13
作者
Lin, Tong [1 ]
Liu, Tiebing [2 ]
Lin, Yucheng [1 ]
Yan, Lailai [3 ]
Chen, Zhongxue [4 ]
Wang, Jingyu [3 ]
机构
[1] Peking Univ, Sch EECS, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China
[2] Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing 100123, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Ctr Med & Hlth Anal, 38 Xue Yuan Rd, Beijing 100191, Peoples R China
[4] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA
基金
中国国家自然科学基金;
关键词
Schizophrenia; Macro elements; Trace elements; Supervised learning methods; COPPER; BIOMARKER; SELENIUM; ZINC; IRON;
D O I
10.1016/j.jtemb.2017.03.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The etiology and pathophysiology of schizophrenia (SCZ) remain obscure. This study explored the associations between SCZ risk and serum levels of 39 macro and trace elements (MTE). A 1:1 matched case-control study was conducted among 114 schizophrenia patients and 114 healthy controls matched by age, sex and region. Blood samples were collected to determine the concentrations of 39 MTE by ICP-AES and ICP-MS. Both supervised learning methods and classical statistical testing were used to uncover the difference of MTE levels between cases and controls. The best prediction accuracies were 99.21% achieved by support vector machines in the original feature space (without dimensionality reduction), and 98.82% achieved by Naive Bayes with dimensionality reduction. More than half of MTE were found to be significantly different between SCZ patients and the controls. The presented investigation showed that there existed remarkable differences in concentrations of MTE between SCZ patients and healthy controls. The results of this study might be useful to diagnosis and prognosis of SCZ; they also indicated other promising applications in pharmacy and nutrition. However, the results should be interpreted with caution due to limited sample size and the lack of potential confounding factors, such as alcohol, smoking, body mass index (BMI), use of antipsychotics and dietary intakes. In the future the application of the analyses will be useful in designs that have larger sample sizes. (C) 2017 Elsevier GmbH. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 31 条
  • [1] Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis
    Alimonti, Alessandro
    Ristori, Giovanni
    Giubilei, Franco
    Stazi, Maria Antonia
    Pino, Anna
    Visconti, Andrea
    Brescianini, Sonia
    Monti, Micaela Sepe
    Forte, Giovanni
    Stanzione, Paolo
    Bocca, Beatrice
    Bomboi, Giuseppe
    D'Ippolito, Cristina
    Annibali, Viviana
    Salvetti, Marco
    Sancesario, Giuseppe
    [J]. NEUROTOXICOLOGY, 2007, 28 (03) : 450 - 456
  • [2] Random forests
    Breiman, L
    [J]. MACHINE LEARNING, 2001, 45 (01) : 5 - 32
  • [3] Psychiatric Comorbidities and Schizophrenia
    Buckley, Peter F.
    Miller, Brian J.
    Lehrer, Douglas S.
    Castle, David J.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 (02) : 383 - 402
  • [4] Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia
    Chiappelli, Joshua
    Rowland, Laura M.
    Wijtenburg, S. Andrea
    Muellerklein, Florian
    Tagamets, Malle
    McMahon, Robert P.
    Gaston, Frank
    Kochunov, Peter
    Hong, L. Elliot
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 (09) : 2157 - 2164
  • [5] Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013
  • [6] Harman H. H., 1976, MODERN FACTOR ANAL, V3rd
  • [7] He X. F., 2003, ADV NEURAL INFORM PR, P153
  • [8] Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics
    Herrán, A
    García-Unzueta, MT
    Fernández-González, MD
    Vázquez-Barquero, JL
    Alvarez, C
    Amado, JA
    [J]. PSYCHIATRY RESEARCH, 2000, 94 (01) : 51 - 58
  • [9] Suicide and schizophrenia: a systematic review of rates and risk factors
    Hor, Kahyee
    Taylor, Mark
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (11) : 81 - 90
  • [10] Life expectancy and cardiovascular mortality in persons with schizophrenia
    Laursen, Thomas M.
    Munk-Olsen, Trine
    Vestergaard, Mogens
    [J]. CURRENT OPINION IN PSYCHIATRY, 2012, 25 (02) : 83 - 88